AccuRna

About:

AccuRna is pioneering unique drug delivery system (DDS) for nucleic acid therapeutics, both of short chain and long chain.

Website: https://accurna.com/

Top Investors: SMBC Venture Capital, NanoCarrier Co, UTokyo Innovation Platform, Fast Track Initiative, Inc.

Description:

AccRna, Inc.'s aim is to promote therapeutic innovation in the form of nucleic acid medicine utilizing our robust DDS platform, providing effective treatment for refractory diseases for which there is currently no cure. Our dream is to deliver a “radical cure” to patients suffering from refractory diseases all over the world by safely and efficiently achieving the ultimate in the therapy utilizing nucleic acid.